Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26
This episode of CNBC's "Fast Money" discusses the surge in Intel and memory stocks, Meta's copyright challenges, Coinbase's workforce changes, and Protagonist Therapeutics' recent drug approval and stock performance.